Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection

ABSTRACT Retrospective epidemiological studies suggest that the licensed serogroup B meningococcal vaccine 4CMenB (Bexsero) provides some protection against the closely related pathogen Neisseria gonorrhoeae in humans. This result has been replicated in murine models of gonococcal colonization, with...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph J. Zeppa, Jamie E. Fegan, Pauline Maiello, Epshita A. Islam, Isaac S. Lee, Christine Pham, Laura-Lee Caruso, Scott D. Gray-Owen
Format: Article
Language:English
Published: American Society for Microbiology 2025-05-01
Series:mSphere
Subjects:
Neisseria gonorrhoeae
4CMenB
Bexsero
T-cell immunity
adaptive immunity
Online Access:https://journals.asm.org/doi/10.1128/msphere.00940-24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.asm.org/doi/10.1128/msphere.00940-24

Similar Items